264 related articles for article (PubMed ID: 19995430)
1. Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes.
Melchor L; Saucedo-Cuevas LP; Muñoz-Repeto I; Rodríguez-Pinilla SM; Honrado E; Campoverde A; Palacios J; Nathanson KL; García MJ; Benítez J
Breast Cancer Res; 2009; 11(6):R86. PubMed ID: 19995430
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel amplification gene targets in mouse and human breast cancer at a syntenic cluster mapping to mouse ch8A1 and human ch13q34.
Abba MC; Fabris VT; Hu Y; Kittrell FS; Cai WW; Donehower LA; Sahin A; Medina D; Aldaz CM
Cancer Res; 2007 May; 67(9):4104-12. PubMed ID: 17483321
[TBL] [Abstract][Full Text] [Related]
3. TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas.
Yasui K; Arii S; Zhao C; Imoto I; Ueda M; Nagai H; Emi M; Inazawa J
Hepatology; 2002 Jun; 35(6):1476-84. PubMed ID: 12029633
[TBL] [Abstract][Full Text] [Related]
4. Recurrent Amplification at 13q34 Targets at CUL4A, IRS2, and TFDP1 As an Independent Adverse Prognosticator in Intrahepatic Cholangiocarcinoma.
Liu TT; You HL; Weng SW; Wei YC; Eng HL; Huang WT
PLoS One; 2015; 10(12):e0145388. PubMed ID: 26684807
[TBL] [Abstract][Full Text] [Related]
5. Gene amplification of the transcription factor DP1 and CTNND1 in human lung cancer.
Castillo SD; Angulo B; Suarez-Gauthier A; Melchor L; Medina PP; Sanchez-Verde L; Torres-Lanzas J; Pita G; Benitez J; Sanchez-Cespedes M
J Pathol; 2010 Sep; 222(1):89-98. PubMed ID: 20556744
[TBL] [Abstract][Full Text] [Related]
6. Dystonia, facial dysmorphism, intellectual disability and breast cancer associated with a chromosome 13q34 duplication and overexpression of TFDP1: case report.
Moscovich M; LeDoux MS; Xiao J; Rampon GL; Vemula SR; Rodriguez RL; Foote KD; Okun MS
BMC Med Genet; 2013 Jul; 14():70. PubMed ID: 23849371
[TBL] [Abstract][Full Text] [Related]
7. CUL4A contributes to the biology of basal-like breast tumors through modulation of cell growth and antitumor immune response.
Saucedo-Cuevas LP; Ruppen I; Ximénez-Embún P; Domingo S; Gayarre J; Muñoz J; Silva JM; García MJ; Benítez J
Oncotarget; 2014 Apr; 5(8):2330-43. PubMed ID: 24870930
[TBL] [Abstract][Full Text] [Related]
8. MYB oncogene amplification in hereditary BRCA1 breast cancer.
Kauraniemi P; Hedenfalk I; Persson K; Duggan DJ; Tanner M; Johannsson O; Olsson H; Trent JM; Isola J; Borg A
Cancer Res; 2000 Oct; 60(19):5323-8. PubMed ID: 11034064
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DPI gene in the 13q34 amplicon.
Shinomiya T; Mori T; Ariyama Y; Sakabe T; Fukuda Y; Murakami Y; Nakamura Y; Inazawa J
Genes Chromosomes Cancer; 1999 Apr; 24(4):337-44. PubMed ID: 10092132
[TBL] [Abstract][Full Text] [Related]
10. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
[TBL] [Abstract][Full Text] [Related]
11. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.
Melchor L; Honrado E; García MJ; Alvarez S; Palacios J; Osorio A; Nathanson KL; Benítez J
Oncogene; 2008 May; 27(22):3165-75. PubMed ID: 18071313
[TBL] [Abstract][Full Text] [Related]
12. CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification.
Klingbeil P; Natrajan R; Everitt G; Vatcheva R; Marchio C; Palacios J; Buerger H; Reis-Filho JS; Isacke CM
Breast Cancer Res Treat; 2010 Feb; 120(1):95-109. PubMed ID: 19350388
[TBL] [Abstract][Full Text] [Related]
13. Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study.
Rodríguez-Pinilla SM; Rodríguez-Gil Y; Moreno-Bueno G; Sarrió D; Martín-Guijarro Mdel C; Hernandez L; Palacios J
Am J Surg Pathol; 2007 Apr; 31(4):501-8. PubMed ID: 17414096
[TBL] [Abstract][Full Text] [Related]
14. Integrated profiling of basal and luminal breast cancers.
Adélaïde J; Finetti P; Bekhouche I; Repellini L; Geneix J; Sircoulomb F; Charafe-Jauffret E; Cervera N; Desplans J; Parzy D; Schoenmakers E; Viens P; Jacquemier J; Birnbaum D; Bertucci F; Chaffanet M
Cancer Res; 2007 Dec; 67(24):11565-75. PubMed ID: 18089785
[TBL] [Abstract][Full Text] [Related]
15. A 1.1Mb deletion in distal 13q deletion syndrome region with congenital heart defect and postaxial polydactyly: additional support for a CHD locus at distal 13q34 region.
Yang YF; Ai Q; Huang C; Chen JL; Wang J; Xie L; Zhang WZ; Yang JF; Tan ZP
Gene; 2013 Oct; 528(1):51-4. PubMed ID: 23639964
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive profiling of 8p11-12 amplification in breast cancer.
Gelsi-Boyer V; Orsetti B; Cervera N; Finetti P; Sircoulomb F; Rougé C; Lasorsa L; Letessier A; Ginestier C; Monville F; Esteyriès S; Adélaïde J; Esterni B; Henry C; Ethier SP; Bibeau F; Mozziconacci MJ; Charafe-Jauffret E; Jacquemier J; Bertucci F; Birnbaum D; Theillet C; Chaffanet M
Mol Cancer Res; 2005 Dec; 3(12):655-67. PubMed ID: 16380503
[TBL] [Abstract][Full Text] [Related]
17. High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer.
Stange DE; Radlwimmer B; Schubert F; Traub F; Pich A; Toedt G; Mendrzyk F; Lehmann U; Eils R; Kreipe H; Lichter P
Clin Cancer Res; 2006 Jan; 12(2):345-52. PubMed ID: 16428471
[TBL] [Abstract][Full Text] [Related]
18. Analysis of DNA repair-related genes in breast cancer reveals CUL4A ubiquitin ligase as a novel biomarker of trabectedin response.
García MJ; Saucedo-Cuevas LP; Muñoz-Repeto I; Fernández V; Robles MJ; Domingo S; Palacios J; Aracil M; Nieto A; Tercero JC; Benítez J
Mol Cancer Ther; 2013 Apr; 12(4):530-41. PubMed ID: 23364677
[TBL] [Abstract][Full Text] [Related]
19. Quantitative PCR--new diagnostic tool for quantifying specific mRNA and DNA molecules: HER2/neu DNA quantification with LightCycler real-time PCR in comparison with immunohistochemistry and fluorescence in situ hybridization.
Schlemmer BO; Sorensen BS; Overgaard J; Olsen KE; Gjerdrum LM; Nexo E
Scand J Clin Lab Invest; 2004; 64(5):511-22. PubMed ID: 15276916
[TBL] [Abstract][Full Text] [Related]
20. Association of over-expressed TFDP1 with progression of hepatocellular carcinomas.
Yasui K; Okamoto H; Arii S; Inazawa J
J Hum Genet; 2003; 48(12):609-613. PubMed ID: 14618416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
